The drug is still in clinical trials, yet wellness clinics are promoting and dispensing copies, and state regulators haven't stepped in, the paper reports.
Recap by typeshit. Full story at The Atlanta Journal-Constitution.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
The Korea Economic Daily says the domestic obesity drug starts at roughly half of Mounjaro's starting price, a new low-cost option for patients in Korea.
Nippard rates the two drugs highly for supervised weight loss and notes that many popular peptide claims lack strong human evidence.
Loading…